NuScriptX Raises $5M in Series C Funding

NuScriptX, a Nashville, Tenn.-based mail order institutional pharmacy, has raised $5m in Series C funding.

The round was led by Council Capital and its TNInvestco arm, Council & Enhanced Tennessee Fund, with participation from existing investors Clayton Associates of Nashville, Tenn., Council Operating Partner Linwood A. (Chip) Lacy Jr. and Envest of Virginia Beach, Va., three other TNInvestco funds – Nest-TN of Tullahoma, Tenn., Tennessee Angel Fund of Nashville, Tenn. (an affiliate of Nashville Capital Network) and Innova of Memphis, Tenn., and an additional unnamed strategic investor

Led by Dennis Bottorff, chairman of the board of directors and Managing General Partner of Capital Council, newly appointed CEO Donald B. Taylor and Jim Beaumariage, the company provides administration of medicines to long-term care nursing facilities in eight states from one pharmacy center in Nashville,Tenn.



Join the discussion